Colgate-Palmolive (NYSE:CL) Downgraded by Wells Fargo & Company

Wells Fargo & Company cut shares of Colgate-Palmolive (NYSE:CLFree Report) from an equal weight rating to an underweight rating in a research note issued to investors on Monday morning, MarketBeat reports. Wells Fargo & Company currently has $100.00 target price on the stock.

CL has been the subject of several other research reports. TD Cowen upped their price objective on Colgate-Palmolive from $110.00 to $115.00 and gave the company a buy rating in a research note on Tuesday, July 30th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a buy rating to a hold rating and raised their price target for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Sanford C. Bernstein boosted their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a market perform rating in a research note on Tuesday, July 30th. Redburn Atlantic raised Colgate-Palmolive to a hold rating in a research note on Thursday, August 1st. Finally, BNP Paribas began coverage on shares of Colgate-Palmolive in a research note on Monday, June 24th. They set an outperform rating and a $109.00 target price for the company. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of Moderate Buy and a consensus target price of $102.79.

Get Our Latest Analysis on CL

Colgate-Palmolive Trading Down 1.2 %

Shares of CL stock opened at $101.98 on Monday. The stock’s fifty day moving average price is $102.61 and its two-hundred day moving average price is $95.65. The company has a market cap of $83.67 billion, a PE ratio of 32.27, a P/E/G ratio of 3.72 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter last year, the business posted $0.77 earnings per share. Equities analysts predict that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.96%. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the sale, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. bought a new position in Colgate-Palmolive during the second quarter valued at about $25,000. Union Savings Bank grew its holdings in Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the period. PSI Advisors LLC increased its position in Colgate-Palmolive by 4,971.4% in the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock worth $32,000 after buying an additional 348 shares during the last quarter. Continuum Advisory LLC raised its stake in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares during the period. Finally, Core Wealth Advisors Inc. lifted its position in shares of Colgate-Palmolive by 56.6% during the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after buying an additional 146 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.